-
2 Georgia schools sign PharmD priority applicant deal
Atlanta-based Mercer University College of Pharmacy secured a deal with another Georgia university to promise priority applicant status for Mercer's PharmD program and cut one school year. -
Local anesthetics shortage prolonged
Local anesthetics bupivacaine and lidocaine have been in unsteady supply since at least 2015, and recently, drugmakers postponed their expected resupply dates again. -
Oncology drugs in shortage: 4 updates
Shortages of a handful of cancer drugs are causing concern as drug companies delay resupply dates and physicians worry about providing adequate care for their patients. -
Mark Cuban's drug company partners with 2 mail-order pharmacies
Mark Cuban Cost Plus Drug Co., a mail-order pharmacy with thousands of generics and a handful of brand-name drugs, has partnered with two mail-order pharmacies. -
Lung cancer drug lowers death risk by 51%
AstraZeneca's approved lung cancer drug Tagrisso (osimertinib) reduced the risk of death by 51 percent in a phase 3 study that involved 682 patients with non-small cell lung cancer. -
U of Utah Health's 5 tips to attract more pharmacy techs
As local pharmacies and hospitals struggle to staff teams with enough pharmacy technicians, Kavish Choudhary, PharmD, chief pharmacy officer of University of Utah Health, told Becker's five pieces of advice. -
FDA allows imported cisplatin from China amid shortage
As drugmakers continue to delay resupply dates for cisplatin, a cancer drug in a monthslong shortage, the FDA allowed a China-based pharmaceutical company to temporarily import some solutions. -
Cuban increases pharmacy labor fee
Mark Cuban Cost Plus Drug Co. will raise its pharmacy labor fee from $3 to $5, effective Sept. 1. -
Pfizer's experimental treatment of superbug infections shows promising results
A phase 3 trial of pharmaceutical giant Pfizer's newly developed antibiotic combination revealed positive results, revealing a promising treatment for superbug infections, according to a June 1 press release. -
NIH to test cancer drug combos against single therapy
The National Institutes of Health's cancer unit is launching the largest study to test combinations of cancer drugs in comparison to the drugs on their own, the organization said June 1. -
Alzheimer's Association at odds with CMS' plan for drug coverage
After CMS announced plans to preserve availability of Alzheimer's drugs, the Alzheimer's Association has issued a statement in opposition of it. -
UF Health specialty pharmacy broadens services, medications offered
University of Florida Health's specialty pharmacy recently expanded its list of medications and accepted insurance plans. -
17 more drugs went into shortage in May
As the U.S. experiences the highest number of drug shortages in 10 years, the FDA and the American Society of Health-System Pharmacists reported 17 new shortages in May. -
FDA approves 2nd RSV vaccine for older adults
The FDA approved the second respiratory syncytial virus vaccine for adults 60 and older on May 31. -
6 things to know about supplement dubbed 'nature's Ozempic'
Berberine, a supplement made from plants, is gaining popularity across social media and online searches as a possible alternative to the expensive, prescription-only drugs like Ozempic and Mounjaro, NBC News reports. -
Cuban's pharmacy to sell Humira biosimilar for $570
Mark Cuban Cost Plus Drug Co. announced that beginning in July it will sell a branded Humira biosimilar known as Yusimry. It is the first biologic product offered by the company. -
New Colorado law restricts diet pills for adolescents
Colorado acting Gov. Dianne Primavera signed legislation May 30 that bans using the body mass index when determining care for eating disorder patients and prohibits the sale of diet pills to people under 18. -
Janssen seeks FDA approval of 1st tablet to treat pulmonary arterial hypertension
Johnson & Johnson-owned Janssen Pharmaceuticals has submitted an application to the FDA for approval of what would be the first tablet therapy for patients with pulmonary arterial hypertension. -
5 notes from the AHA's latest 340B report
Drug prices are rising faster than inflation, according to a new report from the American Hospital Association. -
FDA eyes simplified medication guide for patients
The FDA proposed a new, one-page medication guide outline for prescription drugs and biologics to ensure a "consistent and easy-to-understand format" for patients, the agency said May 30.
Page 1 of 50